A New Paradigm in the Systemic Treatment of Advanced Prostate Cancer: the Earlier the Better or the More the Better
Androgen deprivation therapy (ADT) has been the backbone of treatment for advanced prostate cancer (APC) for decades. The introduction of docetaxel and androgen receptor pathway inhibitors (ARPI; abiraterone, enzalutamide, apalutamide) in the treatment of metastatic hormone- sensitive PC (mHSPC)...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2024-01-01
|
| Series: | Acta Clinica Croatica |
| Subjects: | |
| Online Access: | https://hrcak.srce.hr/file/467303 |